Skip to main content
NCBI home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1993 Mar;99:19–24. doi: 10.1289/ehp.939919

Identification of endogenous electrophiles by means of mass spectrometric determination of protein and DNA adducts.

P B Farmer 1, E Bailey 1, S Naylor 1, D Anderson 1, A Brooks 1, J Cushnir 1, J H Lamb 1, O Sepai 1, Y S Tang 1
PMCID: PMC1567039  PMID: 8319621

Abstract

Monitoring exposure to alkylating agents may be achieved by quantitatively determining the adduct levels formed with nucleic acids and/or proteins. One of the most significant results arising from the application of this approach has been the discovery in control populations of "background" levels of alkylated nucleic acid bases or alkylated proteins, in particular hemoglobin (Hb). In the case of Hb, a wide variety of such adducts have been detected and quantitated by mass spectrometric techniques, with methylated, 2-carboxyethylated, and 2-hydroxyethylated modifications being most abundant. Although the source of these alkylation products is unknown, both endogenous and exogenous sources may be proposed. We have recently confirmed the presence of the N-terminal hydroxyethylvaline adduct in control human Hb using tandem mass spectrometry (MS-MS) and have now established background levels using GC-MS in more than 70 samples. Smoking raises the levels of the adduct up to 10-fold and occupational exposure to ethylene oxide up to 300-fold. Background levels of alkylated nucleic acids may be studied by analysis of N7-alkylated guanine or N3-alkylated adenine, which are excised from nucleic acids after their formation and are excreted in urine. Although the presence of some of these urinary constituents may be accounted for by their natural occurrence in RNA or diet, the endogenous or exogenous source of others is unknown. Quantitative methods using MS-MS have now been developed for five of the observed urinary alkylguanines [N7-methyl-, N2-methyl-, N2-dimethyl-, N7-(2-hydroxyethyl)-, and N2-ethylguanine].(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
19

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BROMBERG P. A., GUTMAN A. B., WEISSMANN B. The purine bases of human urine. II. Semiquantitative estimation and isotope incorporation. J Biol Chem. 1957 Jan;224(1):423–434. [PubMed] [Google Scholar]
  2. Bailey E., Brooks A. G., Bird I., Farmer P. B., Street B. Monitoring exposure to 4,4'-methylenedianiline by the gas chromatography-mass spectrometry determination of adducts to hemoglobin. Anal Biochem. 1990 Nov 1;190(2):175–181. doi: 10.1016/0003-2697(90)90177-b. [DOI] [PubMed] [Google Scholar]
  3. Bailey E., Brooks A. G., Dollery C. T., Farmer P. B., Passingham B. J., Sleightholm M. A., Yates D. W. Hydroxyethylvaline adduct formation in haemoglobin as a biological monitor of cigarette smoke intake. Arch Toxicol. 1988;62(4):247–253. doi: 10.1007/BF00332482. [DOI] [PubMed] [Google Scholar]
  4. Bailey E., Brooks A. G., Farmer P. B., Street B. Monitoring exposure to 4,4'-methylene-bis(2-chloroaniline) through the gas chromatography-mass spectrometry measurement of adducts to hemoglobin. Environ Health Perspect. 1993 Mar;99:175–177. doi: 10.1289/ehp.9399175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bailey E., Connors T. A., Farmer P. B., Gorf S. M., Rickard J. Methylation of cysteine in hemoglobin following exposure to methylating agents. Cancer Res. 1981 Jun;41(6):2514–2517. [PubMed] [Google Scholar]
  6. Bailey E., Farmer P. B., Bird I., Lamb J. H., Peal J. A. Monitoring exposure to acrylamide by the determination of S-(2-carboxyethyl)cysteine in hydrolyzed hemoglobin by gas chromatography-mass spectrometry. Anal Biochem. 1986 Sep;157(2):241–248. doi: 10.1016/0003-2697(86)90621-4. [DOI] [PubMed] [Google Scholar]
  7. Bailey E., Farmer P. B., Tang Y. S., Vangikar H., Gray A., Slee D., Ings R. M., Campbell D. B., McVie J. G., Dubbelman R. Hydroxyethylation of hemoglobin by 1-(2-chloroethyl)-1-nitrosoureas. Chem Res Toxicol. 1991 Jul-Aug;4(4):462–466. doi: 10.1021/tx00022a010. [DOI] [PubMed] [Google Scholar]
  8. Bryant M. S., Skipper P. L., Tannenbaum S. R., Maclure M. Hemoglobin adducts of 4-aminobiphenyl in smokers and nonsmokers. Cancer Res. 1987 Jan 15;47(2):602–608. [PubMed] [Google Scholar]
  9. Byfält Nordqvist M., Löf A., Osterman-Golkar S., Walles S. A. Covalent binding of styrene and styrene-7,8-oxide to plasma proteins, hemoglobin and DNA in the mouse. Chem Biol Interact. 1985 Oct;55(1-2):63–73. doi: 10.1016/s0009-2797(85)80120-4. [DOI] [PubMed] [Google Scholar]
  10. Cathcart R., Schwiers E., Saul R. L., Ames B. N. Thymine glycol and thymidine glycol in human and rat urine: a possible assay for oxidative DNA damage. Proc Natl Acad Sci U S A. 1984 Sep;81(18):5633–5637. doi: 10.1073/pnas.81.18.5633. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Cushnir J. R., Naylor S., Lamb J. H., Farmer P. B. Deuterium exchange studies in the identification of alkylated DNA bases found in urine, by tandem mass spectrometry. Rapid Commun Mass Spectrom. 1990 Oct;4(10):426–431. doi: 10.1002/rcm.1290041018. [DOI] [PubMed] [Google Scholar]
  12. Farmer P. B., Parry A., Franke H., Schmid J. Lack of detectable DNA alkylation for bromhexine in man. Arzneimittelforschung. 1988 Sep;38(9):1351–1354. [PubMed] [Google Scholar]
  13. Farmer P. B., Shuker E. G., Bird I. DNA and protein adducts as indicators of in vivo methylation by nitrosatable drugs. Carcinogenesis. 1986 Jan;7(1):49–52. doi: 10.1093/carcin/7.1.49. [DOI] [PubMed] [Google Scholar]
  14. Gan L. S., Wishnok J. S., Fox J. G., Tannenbaum S. R. Quantitation of methylated hemoglobin via hydrolysis of methyl esters to yield methanol. Anal Biochem. 1989 Jun;179(2):326–331. doi: 10.1016/0003-2697(89)90137-1. [DOI] [PubMed] [Google Scholar]
  15. Kautiainen A., Törnqvist M., Anderstam B., Vaca C. E. In vivo hemoglobin dosimetry of malonaldehyde and ethene in mice after induction of lipid peroxidation. Effects of membrane lipid fatty acid composition. Carcinogenesis. 1991 Jun;12(6):1097–1102. doi: 10.1093/carcin/12.6.1097. [DOI] [PubMed] [Google Scholar]
  16. Manchester D. K., Weston A., Choi J. S., Trivers G. E., Fennessey P. V., Quintana E., Farmer P. B., Mann D. L., Harris C. C. Detection of benzo[a]pyrene diol epoxide-DNA adducts in human placenta. Proc Natl Acad Sci U S A. 1988 Dec;85(23):9243–9247. doi: 10.1073/pnas.85.23.9243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Ohmori S., Shimomura T., Azumi T., Mizuhara S. S-(beta-carboxy-n-propyl)-L-cysteine and S-(beta-carboxyethyl)-L-cysteine in urine. Biochem Z. 1965 Nov 5;343(1):9–15. [PubMed] [Google Scholar]
  18. Osterman-Golkar S., Farmer P. B., Segerbäck D., Bailey E., Calleman C. J., Svensson K., Ehrenberg L. Dosimetry of ethylene oxide in the rat by quantitation of alkylated histidine in hemoglobin. Teratog Carcinog Mutagen. 1983;3(5):395–405. doi: 10.1002/1520-6866(1990)3:5<395::aid-tcm1770030502>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  19. Paik W. K., Kim S. Protein methylation. Science. 1971 Oct 8;174(4005):114–119. doi: 10.1126/science.174.4005.114. [DOI] [PubMed] [Google Scholar]
  20. Perera F. P., Santella R. M., Brenner D., Poirier M. C., Munshi A. A., Fischman H. K., Van Ryzin J. DNA adducts, protein adducts, and sister chromatid exchange in cigarette smokers and nonsmokers. J Natl Cancer Inst. 1987 Sep;79(3):449–456. [PubMed] [Google Scholar]
  21. Prevost V., Shuker D. E., Bartsch H., Pastorelli R., Stillwell W. G., Trudel L. J., Tannenbaum S. R. The determination of urinary 3-methyladenine by immunoaffinity chromatography-monoclonal antibody-based ELISA: use in human biomonitoring studies. Carcinogenesis. 1990 Oct;11(10):1747–1751. doi: 10.1093/carcin/11.10.1747. [DOI] [PubMed] [Google Scholar]
  22. Sherson D., Sabro P., Sigsgaard T., Johansen F., Autrup H. Biological monitoring of foundry workers exposed to polycyclic aromatic hydrocarbons. Br J Ind Med. 1990 Jul;47(7):448–453. doi: 10.1136/oem.47.7.448. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Shuker D. E., Bailey E., Parry A., Lamb J., Farmer P. B. The determination of urinary 3-methyladenine in humans as a potential monitor of exposure to methylating agents. Carcinogenesis. 1987 Jul;8(7):959–962. doi: 10.1093/carcin/8.7.959. [DOI] [PubMed] [Google Scholar]
  24. Tates A. D., Grummt T., Törnqvist M., Farmer P. B., van Dam F. J., van Mossel H., Schoemaker H. M., Osterman-Golkar S., Uebel C., Tang Y. S. Biological and chemical monitoring of occupational exposure to ethylene oxide. Mutat Res. 1991 Sep-Oct;250(1-2):483–497. doi: 10.1016/0027-5107(91)90205-3. [DOI] [PubMed] [Google Scholar]
  25. Törnqvist M., Gustafsson B., Kautiainen A., Harms-Ringdahl M., Granath F., Ehrenberg L. Unsaturated lipids and intestinal bacteria as sources of endogenous production of ethene and ethylene oxide. Carcinogenesis. 1989 Jan;10(1):39–41. doi: 10.1093/carcin/10.1.39. [DOI] [PubMed] [Google Scholar]
  26. Törnqvist M., Mowrer J., Jensen S., Ehrenberg L. Monitoring of environmental cancer initiators through hemoglobin adducts by a modified Edman degradation method. Anal Biochem. 1986 Apr;154(1):255–266. doi: 10.1016/0003-2697(86)90524-5. [DOI] [PubMed] [Google Scholar]
  27. Törnqvist M., Osterman-Golkar S., Kautiainen A., Näslund M., Calleman C. J., Ehrenberg L. Methylations in human hemoglobin. Mutat Res. 1988 Mar;204(3):521–529. doi: 10.1016/0165-1218(88)90046-8. [DOI] [PubMed] [Google Scholar]
  28. Van Sittert N. J., de Jong G., Clare M. G., Davies R., Dean B. J., Wren L. J., Wright A. S. Cytogenetic, immunological, and haematological effects in workers in an ethylene oxide manufacturing plant. Br J Ind Med. 1985 Jan;42(1):19–26. doi: 10.1136/oem.42.1.19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Wogan G. N. Markers of exposure to carcinogens. Environ Health Perspect. 1989 May;81:9–17. doi: 10.1289/ehp.89819. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of American Chemical Society

RESOURCES